First Long-Term Data on Atogepant for Migraine Prevention

An ongoing extension study supports the long-term safety and efficacy of the oral CGRP receptor antagonist atogepant in preventing chronic and episodic migraine. 70% of patients treated with atogepant achieved…

admin admin

Know All About Deadly Infection

A 37-year-old man in Hong Kong tested positive for the rare human B virus after being attacked by a wild monkey. The virus can lead to severe brain damage or…

admin admin

Netarsudil and latanoprost combo useful fixed dose option for open-angle glaucoma and IOP: Study

A study has found that a combination of netarsudil and latanoprost is a useful fixed dose option for treating open-angle glaucoma and reducing intraocular pressure (IOP). This combination therapy was…

admin admin

EConsent Workflows Must Evolve to Support Interoperability and Health Equity

A webinar on April 16 at 1pm ET will discuss how healthcare organizations and health tech companies can collaborate to improve interoperability through eConsent, moderated by Aneesh Chopra. The panel,…

admin admin

Government approves further expansion of role of pharmacists 

The Cabinet has approved new legislative amendments to expand pharmacists' responsibilities, including the ability to prescribe. The Expert Taskforce on Pharmacy in Ireland has been reviewing the role of pharmacists…

admin admin

Why Opioid Settlement Money Is Paying County Employees’ Salaries

More than $4.3 billion in opioid settlement funds have been distributed to city, county, and state officials, with more to come. However, some places are using the money to replace…

admin admin

Standards of Care encourages more people with diabetes to use CGM

The 2024 ADA Standards of Care recommend continuous glucose monitoring (CGM) for all people with type 1 diabetes. CGM, along with certain insulins, can help people recognize, prevent, and treat…

admin admin

Intra-Cellular reports positive results in depression study

Intra-Cellular Therapies announced positive results from a Phase 3 clinical trial for its antipsychotic medicine Caplyta in treating major depressive disorder. The study showed a significant reduction in depressive symptoms…

admin admin

NHS England does U turn on staff mental health service after outcry by doctors

NHS England has initially decided to stop accepting new sign-ups to the NHS Practitioner Health program, which provides mental health and addiction services to healthcare professionals. This decision sparked dismay…

admin admin

New guidelines reflect growing use of AI in health care research

New guidelines called TRIPOD+AI have been introduced to update the reporting standards for clinical prediction models, reflecting the increasing use of artificial intelligence (AI) in medical decision-making tools. These guidelines…

admin admin
error: Content is protected !!